Pharmaceutical Analytical Testing Market Report 2026

The pharmaceutical analytical testing market size has grown strongly in recent years. It will grow from $8.21 billion in 2025 to $8.94 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to expansion of pharmaceutical manufacturing activities, increasing regulatory scrutiny on drug quality, growth in generic drug development, rising investments in R&D pipelines, expansion of global testing laboratory networks.

The pharmaceutical analytical testing market size is expected to see strong growth in the next few years. It will grow to $12.46 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing demand for complex biologics testing, rising adoption of automated analytical platforms, expansion of personalized medicine development, growing focus on faster regulatory approvals, increasing reliance on contract testing organizations. Major trends in the forecast period include increasing adoption of advanced analytical testing techniques, rising demand for outsourced testing services, growing focus on regulatory-compliant testing protocols, expansion of stability and bioanalytical testing, enhanced integration of automation in testing laboratories.

The increasing number of drug approvals and clinical trials is expected to drive growth in the pharmaceutical analytical testing market in the coming years. Drug approvals and trials involve the regulated evaluation of new medications for safety and efficacy through clinical testing, followed by official authorization from health authorities for public use. The rise in drug approvals and trials is largely driven by advancements in precision medicine, which enable the development of highly targeted therapies tailored to individual genetic profiles, increasing the likelihood of therapeutic success and regulatory clearance. Pharmaceutical analytical testing plays a critical role in this process by ensuring the safety, efficacy, and quality of drug products through validated data on stability, impurities, bioavailability, and pharmacokinetics, supporting regulatory compliance and informed decision-making. For example, in December 2024, according to the Association of the British Pharmaceutical Industry, the number of industry-sponsored clinical trials initiated in the United Kingdom increased from 411 in 2022 to 426 in 2023, while Phase III trial initiations rose by 16.5%, from 182 to 212. Consequently, the rising number of drug approvals and trials is propelling the pharmaceutical analytical testing market.

Key companies in the pharmaceutical analytical testing market are introducing innovative solutions, such as digital reference materials platforms, to improve the accuracy, traceability, and efficiency of laboratory testing processes, ensuring regulatory compliance and enhancing data integrity. A digital reference materials platform is an online or software-based system providing authenticated, standardized datasets or models used to calibrate, validate, and verify analytical testing in pharmaceutical laboratories. For instance, in November 2023, Merck Group, a Germany-based pharmaceutical company, launched ChemisTwin, the first digital reference materials platform for analytical testing, which automates the analysis of sample purity, compound identification, and degradation using algorithm-based digital references. With digital signatures for over 1,500 reference materials, ChemisTwin streamlines workflows in pharmaceutical quality control, quality assurance, and R&D by providing traceable digital records linked to physical reference materials, reducing manual tasks, enhancing sampling rates, and improving detection of sample inconsistencies.

In April 2025, Eureka Analytical Services Pvt Ltd., an India-based provider of testing, inspection, and auditing services, acquired Teena Biolabs Pvt Ltd. for an undisclosed amount. Through this acquisition, Eureka aims to expand its pharmaceutical analysis services in India, serve the market more comprehensively, and position both Eureka and the GBA Group as leading laboratory analysis providers in the country. Teena Biolabs Pvt Ltd. is an India-based contract testing laboratory specializing in analytical testing services for the pharmaceutical and biotech sectors, with a strong focus on quality and regulatory compliance.

Major companies operating in the pharmaceutical analytical testing market are Thermo Fisher Scientific Inc., Merck KGaA, IQVIA Holdings Inc., Laboratory Corporation of America Holdings, ICON Public Limited Company, Eurofins Scientific SE, Pharmaceutical Product Development LLC, WuXi AppTec Co. Ltd., Syneos Health Inc., Steris plc, Catalent Inc., Charles River Laboratories International Inc., Intertek Group plc, SGS Société Générale de Surveillance SA, Almac Group Limited, Pace Analytical Services LLC, Neotron S.p.A., Toxikon Corporation, Element Materials Technology Group Limited, Boston Analytical Inc., ALS Limited, Frontage Laboratories Inc.

North America was the largest region in the pharmaceutical analytical testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical analytical testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharmaceutical analytical testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the pharmaceutical analytical testing market by increasing costs of imported analytical instruments, chromatography systems, reagents, consumables, and laboratory automation equipment. Testing laboratories and pharmaceutical manufacturers in North America and Europe are most affected due to dependence on imported high-end instruments, while Asia-Pacific faces higher costs for advanced testing infrastructure. These tariffs are raising operational costs and slowing laboratory expansion plans. However, they are also encouraging local instrument manufacturing, regional supplier partnerships, and development of cost-optimized analytical testing solutions.

The pharmaceutical analytical testing market research report is one of a series of new reports that provides pharmaceutical analytical testing market statistics, including pharmaceutical analytical testing industry global market size, regional shares, competitors with a pharmaceutical analytical testing market share, detailed pharmaceutical analytical testing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical analytical testing industry. This pharmaceutical analytical testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pharmaceutical analytical testing involves the comprehensive evaluation of pharmaceutical products using a variety of scientific techniques to assess their physical, chemical, biological, and microbiological properties, ensuring they meet established quality, safety, and efficacy standards. This testing is a critical part of the drug development and manufacturing process, as it confirms the identity, purity, potency, and stability of drug products in compliance with regulatory requirements.

The primary types of services in pharmaceutical analytical testing include bioanalytical testing, method development and validation, stability testing, drug substance testing, microbial testing, physical characterization, and others. Bioanalytical testing measures drugs, metabolites, and biomarkers in biological samples such as blood or urine. It employs techniques like chromatography, spectroscopy, mass spectrometry, electrophoresis, and microscopy for applications including quality control, research and development, regulatory compliance, drug approval and registration, and post-marketing surveillance. These services are used by pharmaceutical companies, contract research organizations (CROs), academic institutions, regulatory agencies, and testing laboratories.

The pharmaceutical analytical testing market includes revenues earned by entities by providing services, such as method development and validation, stability testing, quality control testing, raw material testing, impurity profiling, and elemental analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.